Paris

• Study in highly sensitised kidney transplant patients with a high degree of antibodies against the donor's kidney to see the efficacy and sa … Ended
  2024-511810-18-00 5 2022-04-19 End stage chronic kidney disease (CKD) patients who are highly sensiti
• Open-label extesnion study of soticlestat in Dravet and Lennox-Gastaut Syndromes Ended
  2022-502802-34-00 5 2022-04-05 Dravet and Lennox-Gastaut Syndromes
• Tamibarotene/Venetoclax/Azacitidine in Previously Untreated Patients Selected for RARA-positive AML (SELECT-AML-1) Ended
  2024-510939-21-00 4 2022-04-01 RARA-positive acute myeloid leukemia
• ​​Sotorasib and Panitumumab Versus Investigator’s Choice for Subjects with KRAS p.G12C Mutation (CodeBreaK 300)​ Ended
  2024-511187-81-00 5 2022-03-28 Colorectal Cancer (CRC)
• AcTIVE - ACid tranexamic or Terlipressin for Initial emergency treatment of mild to seVere hEmoptysis: a randomized Trial Ended
  2024-515010-40-00 5 2022-03-28 Hemoptysis, whatever the cause, with the exception of cystic fibrosis
• Brightline-1: A study to compare brigimadlin (BI 907828) with doxorubicin in people with a type of cancer called dedifferentiated liposarcom … Ended
  2024-511361-11-00 10 2022-03-25 Advanced dedifferentiated liposarcoma
• HEMolyse and Organ damage imPROvement in sickle cell disease by VoxElotor Ended
  2024-513096-41-00 4 2022-03-24 sickle cell disease
• A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Familial Chylomicronemia Syndrome Ended
  2024-514336-24-00 5 2022-03-24 Familial Chylomicronemia Syndrome (FCS)
• PICASSO. Prospective randomIzed clinical trial assessing the tolerance and clinical benefit of feCAl tranSplantation in patientS with melanO … Ended
  2024-516100-42-00 4 2022-03-18 Melanoma
• Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections … Ended
  2023-510088-37-00 5 2022-03-15 Acyclovir-resistant mucocutaneous HSV infections in immunocompromised
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia. Ended
  2024-510696-38-00 5 2022-03-08 Severe Hypertriglyceridemia.
• A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-in-human (FIH) Proof of Concept (PoC) study to … Ended
  2023-507743-11-00 7 2022-02-18 Netherton syndrome (NS)
• Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency Ended
  2024-516021-32-00 5 2022-02-17 Critically ill patients suffering from CIRCI
• A study to evaluate the efficacy and safety of olorofim versus AmBisome® for treatment of invasive aspergillosis Ended
  2024-513030-38-00 5 2022-02-15 Invasive fungal infections due to Aspergillus spp.
• Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumours Ended
  2024-511071-16-00 3 2022-02-10 Solid Tumours
• Isatuximab in type I cryoglobulinemia: A prospective pilot study ICE STUDY Ended
  2024-515039-31-00 4 2022-02-10 Isatuximab in type I cryoglobulinaemia: A prospective pilot study
• Evaluating the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Ended
  2023-508820-37-00 5 2022-02-03 Cytomegalovirus Infection (CMV)
• Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J … Ended
  2023-505457-40-00 5 2022-02-02 Previously Untreated Advanced Gastric or Gastroesophageal Junction Can
• Study to evaluate Pegcetacoplan in patients with TA-TMA after hematopoietic stem cell transplantation Ended
  2023-510443-37-00 4 2022-01-26 Transplant-associated Thrombotic Microangiopathy (TA TMA)
• Study comparing the standard administration of immunotherapy (IO) versus the same agent administered each three months in patients with loca … Ended
  2024-513707-14-00 5 2022-01-14 Only patients with oncologic locally advanced or metastatic tumour (lu
• FAMODREP : Interest of Famotidine in Reducing Endothelial Expression of P-selectin in Children With Sickle Cell Disease: Pilot Study, Single … Ended
  2022-502144-12-00 6 2022-01-12 Sickle Cell Disease
• A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination with Cetrelimab and Cetrelimab Alone in Participants with Mu … Ended
  2023-507189-17-00 4 2022-01-09 Muscle-Invasive Urothelial Carcinoma of the Bladder
• GEN1047 for Solid Tumors - First in Human (FIH) Trial Ended
  2024-510722-10-00 7 2021-12-13 Malignant Solid Tumors
• A randomized non-inferiority clinical trial of doxycycline vs BPG for early syphilis Ended
  2024-513532-23-00 5 2021-12-06 early syphilis

Showing 2,065–2,088 of 2,286 trials